The FDA has approved a generic version of lenalidomide, a drug used to treat multiple myeloma and myelodysplastic syndromes, with availability set for Jan. 31, 2026.

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than ...

Alembic is introducing diltiazem hydrochloride extended-release capsules 120 mg, 180 mg and 240 mg, which are the generic of ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...